Wednesday, September 7, 2016

UPDATE 3-Retrophin kidney drug exceeds expectations in trial, shares jump

* Retrophin shares rise as much as 44 pct

(Adds details from conference call, analyst comment; updates

shares)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)